$220.00 Original price was: $220.00.$150.00Current price is: $150.00.
Out of stock
Each unit corresponds to one research vial. For laboratory use only.
Re-tested & Quality-Verified
Warehouse Shipping All orders are shipped from our Canadian warehouse. Products are re-tested and quality-verified in Canadian laboratories prior to domestic shipment. This includes expedited Canadian re-test handling, ensuring additional quality verification steps are completed in domestic facilities. Products undergo additional quality control testing in Canada before shipment, with faster domestic delivery times. An expedited handling fee applies to all orders.
Studies involving GH 100iu laboratory research have examined the areas below. Results vary by model, and the limits matter when interpreting them.
Bottom line: these points describe research areas and evidence limits, not product benefits or treatment advice.
GH 100iu laboratory research product information: this material is supplied as one 100 IU vial for qualified laboratory and analytical research in Canada. It is not a medicine, supplement or cosmetic, and it is not intended for human or veterinary use.
Research-use notice: this listing does not provide dosing, administration or reconstitution instructions. Researchers must follow an approved protocol, institutional safety rules and the current batch documentation.

| Listed product | GH 100iu |
|---|---|
| Research format | one 100 IU vial |
| Material class | Growth hormone protein research material |
| Research area | growth-hormone receptor and endocrine research |
| Intended use | Qualified laboratory and analytical research |
| Prohibited use | Not for human or veterinary use |
Researchers should verify identity, concentration and lot-specific documentation before including any material in an experiment. A catalogue name or nominal vial amount does not replace analytical confirmation.
Growth hormone is a protein hormone that signals through the growth hormone receptor and influences IGF-axis and metabolic pathways. Laboratory work may examine receptor activation, downstream signalling and assay calibration.
Authorized somatropin medicines have defined identity, potency, formulation and clinical indications. A catalogue research vial must not be assumed equivalent or used therapeutically.
Canadian buyers should distinguish a research material from an authorized therapeutic product. Health Canada maintains the Drug Product Database for checking authorized medicines and their product monographs. A research-use label does not create therapeutic authorization or establish safety for personal use.
For scientific literature, begin with a focused PubMed search for GH 100iu and review study design, model, controls, material identity and conflicts of interest. Evidence from cells or animals cannot establish a clinical benefit in people.
Research themes include GHR binding, JAK–STAT signalling, IGF-related biomarkers, receptor internalization and endocrine feedback.
Clinical knowledge about authorized growth hormone does not establish quality, safety or benefit for an unapproved research product. Bodybuilding, anti-ageing and performance use are outside this listing.
Good laboratory procurement begins with identity and lot traceability. Review the certificate of analysis, lot number, manufacture or testdate, stated method, chromatogram or spectrum where available, acceptance criteria and storage conditions. Confirm that the document refers to the exact lot received.
A certificate of analysis is useful evidence, but it is not proof that a research product is safe for people or suitable for every experimental system.
Verify protein identity, aggregation, potency assignment and lot-specific storage. Use receptor-specific controls and distinguish immunoreactivity from functional bioactivity.
Define the research question, model, controls, replicates, endpoints and exclusion criteria before opening the vial. Record instrument settings and deviations so results remain reproducible. Do not extrapolate a laboratory result into a medical claim.
Restrict access to trained personnel. Use suitable personal protective equipment and engineering controls based on the laboratory’s risk assessment. Keep the product in its labelled container, prevent cross-contamination, and follow the current product documentation for storage. Dispose of unused material and contaminated consumables under institutional and local requirements.
For broader context, read what peptides are and how safety evidence is assessed, the guide to research peptides and scientific interest, and the overview of research-peptide sourcing considerations in Canada.
It is growth hormone protein research material supplied as one 100 IU vial for qualified laboratory and analytical work only.
This research product is not presented as a Health Canada-authorized medicine and is not intended for human or veterinary use. Consult the official Drug Product Database for authorized products.
No. Research use only describes controlled laboratory work; it does not permit personal consumption, treatment or performance enhancement.
Prioritize peer-reviewed primary studies, systematic reviews, official regulatory information and complete methods. Check whether findings come from cells, animals or controlled human research.
Review identity, purity or composition, quantity, lot traceability, test methods and contamination controls that match the intended experiment.
No. A COA can support analytical quality for a specific lot, but it does not demonstrate clinical safety, efficacy or regulatory approval.
It connects the received vial to analytical results and helps laboratories investigate variability, deviations and reproducibility.
No. Preclinical findings generate hypotheses and cannot establish that a product safely treats, prevents or cures a condition in people.
No. It intentionally omits administration, dosing and reconstitution guidance because the product is restricted to laboratory research.
Use Health Canada resources for regulatory status, PubMed for scientific literature, and the linked Canadian research-peptide guides for procurement and evidence context.
GH 100iu is supplied solely for qualified laboratory and analytical research. It is not intended for human or veterinary use and is not offered to diagnose, treat, cure or prevent any disease.
Regulatory Notice:
This product has not been evaluated by the Food and Drug Administration (FDA). It is not approved for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease.
Important Research Note:
The information provided on this website is for research and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment. Consult with qualified healthcare professionals for medical guidance.
Safety & Handling Disclaimer:
Products are sold “as is” without warranty. The buyer assumes all risk and liability for the results obtained by the use of any product. Use at your own risk.
Important Research Note:
The information provided on this website is for research and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment. Consult with qualified healthcare professionals for medical guidance.
Safety & Handling Disclaimer:
Products are sold “as is” without warranty. The buyer assumes all risk and liability for the results obtained by the use of any product. Use at your own risk.
You must be 18 or 19 years of age depending on the age of majority in your province and a licensed research professional
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. No dosing instructions are provided. We adhere to all provincial and federal laws in Canada around Research Only Chemical sales. We are not a pharmacy and/or compounding facility, nor do we promote or provide any advice for human or animal consumption.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above.